Spots Global Cancer Trial Database for Improving Muslim Women's Uptake of Cancer Screening (IMCAN)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Improving Muslim Women's Uptake of Cancer Screening (IMCAN)

Official Title: Improving Uptake of Breast, Bowel and Cervical Cancer Screening Among Muslim Women: a Non-randomised Feasibility Study of a Peer-led, Faith-based Intervention

Study ID: NCT06106165

Conditions

Breast Cancer

Bowel Cancer

Cervical Cancer

Interventions

In-person peer-led faith-based intervention to encourage breast, bowel, and cervical screening uptake among Muslim women

Online In-person peer-led faith-based intervention to encourage breast, bowel, and cervical screening uptake among Muslim women

Study Description

Brief Summary: The goal of this non-randomised trial is to test how a workshop that includes religiously-tailored messages can help increase the uptake of breast, colorectal and cervical cancer screening among Muslim women in North East England and Scotland. The results of this trial will inform the development of a full-scale randomised-controlled trial. Participants in this study will be asked to take part in a two-hour workshop, deliver either online or in-person.

Detailed Description: Low rates of cancer screening among Muslim women puts them at higher risk of death from screening since they do not detect cancer early. This study will work to increase the uptake of cancer screening among Muslim women using two-hour workshops delivered in the community. The workshops were developed with the help of 10 Muslim women in Scotland. The workshops include four parts: * A discussion on the barriers and facilitators to breast, cervical and colorectal cancer screening * A health information session given by a female health provider on cancer screening * Videos of Muslim women talking about their experiences with cancer screening * A session given by a female religious scholar to discuss Islamic perspectives on cancer screening. Another eighteen Muslim women then took part in the workshops; they gave positive feedback on the content of the workshops and how the sessions were delivered. In the feasibility trial, the workshops will be delivered to 200 Muslim women to find out whether a full-scale randomised-controlled trial can take place. This study will be carried out with the help of 10 Muslim women who will give advice on the content of the workshops and plan for implementation; they will also help with the delivery of the workshops. It is expected that this study will lead to changes in knowledge and screening uptake among participants.